Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer letters

Showing results (661-670 of 16,578) with videos related to

Pageof 1,658
Sort By:
Cancer Letters|April 4, 2008
Anticancer drugs and central nervous system: clinical issues for patients and physiciansAlessandro M Minisini, Giada Pauletto, Claudia Andreetta, et al.
Cancer Letters|April 15, 2008
Cortactin in tumor invasivenessAlissa M Weaver
Cancer Letters|May 13, 2008
Enhanced anti-tumor immunity generated by Rituximab-coated tumor cell vaccineHuili Wang, Dongmei Wang, Mengqiang Li, et al.
Cancer Letters|May 16, 2008
Differential effects of photodynamic therapy on morphologically distinct tumor cells derived from a single precursor cellToshihiro Kushibiki, Makoto Sakai, Kunio Awazu
Cancer Letters|May 16, 2008
Multi-targeted therapy of cancer by omega-3 fatty acidsIsabelle M Berquin, Iris J Edwards, Yong Q Chen
Cancer Letters|March 25, 2008
Up-regulation of p21WAF1/Cip1 by saRNA induces G1-phase arrest and apoptosis in T24 human bladder cancer cellsKai Yang, Xiang-Yi Zheng, Jie Qin, et al.
Cancer Letters|March 26, 2008
Reactive oxygen species in tumor metastasisMakiya Nishikawa
Cancer Letters|March 28, 2008
Molecular and genetic changes in asbestos-related lung cancerPenny Nymark, Harriet Wikman, Tuija Hienonen-Kempas, et al.
Cancer Letters|March 28, 2008
Enhancing ultrasound-mediated cell membrane permeabilisation (sonoporation) using a high frequency pulse regime and implications for ultrasound-aided cancer chemotherapyYing Suet Li, Cherith N Reid, Anthony P McHale
Cancer Letters|May 9, 2008
The heat shock protein antagonist 17-AAG potentiates the activity of enzastaurin against malignant human glioma cellsEsther P Jane, Ian F Pollack
Pageof 1,658

Showing results (661-670 of 16,578) with videos related to

Sort By:
Pageof 1,658
Cancer Letters|April 4, 2008
Anticancer drugs and central nervous system: clinical issues for patients and physiciansAlessandro M Minisini, Giada Pauletto, Claudia Andreetta, et al.
Cancer Letters|April 15, 2008
Cortactin in tumor invasivenessAlissa M Weaver
Cancer Letters|May 13, 2008
Enhanced anti-tumor immunity generated by Rituximab-coated tumor cell vaccineHuili Wang, Dongmei Wang, Mengqiang Li, et al.
Cancer Letters|May 16, 2008
Differential effects of photodynamic therapy on morphologically distinct tumor cells derived from a single precursor cellToshihiro Kushibiki, Makoto Sakai, Kunio Awazu
Cancer Letters|May 16, 2008
Multi-targeted therapy of cancer by omega-3 fatty acidsIsabelle M Berquin, Iris J Edwards, Yong Q Chen
Cancer Letters|March 25, 2008
Up-regulation of p21WAF1/Cip1 by saRNA induces G1-phase arrest and apoptosis in T24 human bladder cancer cellsKai Yang, Xiang-Yi Zheng, Jie Qin, et al.
Cancer Letters|March 26, 2008
Reactive oxygen species in tumor metastasisMakiya Nishikawa
Cancer Letters|March 28, 2008
Molecular and genetic changes in asbestos-related lung cancerPenny Nymark, Harriet Wikman, Tuija Hienonen-Kempas, et al.
Cancer Letters|March 28, 2008
Enhancing ultrasound-mediated cell membrane permeabilisation (sonoporation) using a high frequency pulse regime and implications for ultrasound-aided cancer chemotherapyYing Suet Li, Cherith N Reid, Anthony P McHale
Cancer Letters|May 9, 2008
The heat shock protein antagonist 17-AAG potentiates the activity of enzastaurin against malignant human glioma cellsEsther P Jane, Ian F Pollack
Pageof 1,658